Sort by:

select Language:

Venomous snake bites: clinical diagnosis and treatment

Toru Hifumi et al., (2015)

Article published in: Journal of Intensive Care (2015) 3:16

Rabies vaccines: WHO position paper – April 2018

World Health Organization (WHO), (2018)

Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE

Guidelines for the production, control and regulation of snake antivenom immunoglobulins

[World Health Organization (WHO)], (2017)

Replacement of Annex 2 of WHO Technical Report Series, No. 964

Eradication of yaws – procedures for verification and certification of interruption of transmission

K. Asiedu, Eds.: World Health Organisation (WHO), (2018)

This document sets out the criteria and procedures to be followed by countries in verifying the interruption of yaws transmission. It is intended for use by international verification teams, national yaws eradication programmes and WHO technical staff involved in the eradication of yaws.

Eradication of yaws: a guide for programme managers

World Health Organization WHO, (2018)

This document provides guidance for countries on how to implement activities to achieve the interruption of yaws transmission. It is intended for use by national yaws eradication programmes, partners involved in the implementation of yaws eradication activities and WHO technical staff who provide technical support to countries in the eradication of yaws.

Guidelines for the Management of Snake-bites. 2nd edition

Word Health Organization/ Regional Office of South-East Asia, Eds.: Word Health Organization/ Regional Office of South-East Asia, (2016)

Snakebites are well-known medical emergencies in many parts of the world, especially in rural areas. Agricultural workers and children are the most affected. The incidence of snakebite mortality is particularly high in South-East Asia. Rational use of snake anti-venom can substantially reduce mortality and morbidity due to snakebites. These guidelines are a revised and updated version of Regional Guidelines for the Management of snakebites published by the WHO Regional Office in South-East Asia in 2011. These guidelines aim to promote the rational management of snakebite cases in various health facilities where trained health functionaries and quality snake antivenom are available.

Comparative efficacy of low-dose versus standard-dose azithromycin for patients with yaws: a randomised non-inferiority trial in Ghana and Papua New Guinea

Marks, M.; O. Mitja; C. Bottomley, et al., (2018)

n this study, low-dose azithromycin did not meet the prespecified non-inferiority margin compared with standard-dose azithromycin in achieving clinical and serological cure in PCR-confirmed active yaws. Only a single participant (with presumed latent yaws) had definitive serological failure. This work suggests that 20 mg/kg of azithromycin is probably effective against yaws, but further data are needed.

Prise en charge clinique des cas de fièvre hémorragique virale

World Health Organization, Regional Office for Africa;, (2016)

Guide de poche pour l’agent de santé en première ligne Ce guide s’intéresse plus particulièrement à certaines fièvres hémorragiques virales (FHV) Ebola, Marburg, FHCC, fièvre de Lassa [et Lujo] – qui surviennent en Afrique et risquent de donner lieu à une transmission interhumaine. Il ne traite pas de la prise en charge d’autres infections virales, comme la dengue, la fièvre de la vallée du Rift et la fièvre jaune, qui entraînent également des manifestations hémorragiques, mais pour lesquelles il n’y a pas de transmission directe d’une personne à une autre

Weekly Epidemiological Record (WER), 25 May 2018, vol. 93, no. 21 (pp.305–320) [EN/FR]

World Health Organization, (2018)

Contents 305 Dracunculiasis eradication: global surveillance summary, 2017

184 hits